Evidence map›Paper›PMID 39833888›Full record

ArticleJournal of cannabis research2025

Peer-review Blinded Assay Test (P-BAT): a framework for trustless laboratory quality assurance for state-regulated cannabis markets.

Stuart Procter, Grayson L Baird, Jason Iannuccilli

Abstract readLetter
In one paragraph

Article in Journal of cannabis research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Stuart ProcterPureVita Labs LLC, 153 James P Murphy Ind Hwy , West Warwick, 02893-2382, United States.
Grayson L BairdPureVita Labs LLC, 153 James P Murphy Ind Hwy , West Warwick, 02893-2382, United States.
Jason IannuccilliPureVita Labs LLC, 153 James P Murphy Ind Hwy , West Warwick, 02893-2382, United States. jiannuccilli@purevitalabs.com.ORCID http://orcid.org/0000-0001-6748-1433

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of laboratory testing in the cannabis industry is to ensure public safety by preventing products that exceed hazardous limits of contaminants from reaching consumers, and to provide consumers with transparent and accurate label information so that they can make informed decisions when purchasing and using products. However, cannabis testing does not exist in a vacuum of incentives-some incentives exist that are in direct conflict with what is best for consumers. For example, cultivators and distributors will prefer to use the services of laboratories that find the highest THC concentrations or lowest contaminant concentrations, regardless of the accuracy of their testing results. Laboratories will, therefore, be incentivized to serve the cultivators and distributors over the end consumer. The present essay proposes a framework for quality assurance that combats these perverse incentives. The following proposed framework called the Peer-review Blinded Assay Test (P-BAT), is a validation process where each laboratory tests products from competing labs and their own lab, but in a blinded fashion to ensure that the label values of said products and the labs that produced said labels, are unknown. This system of blinded self-review and peer-review is designed to be cost-efficient, transparent, nearly self-funded, can be implemented in any state with two or more laboratories, and most importantly, it is trustless-there is no need to trust the behavior of any one actor or laboratory to serve as a "gold standard". While the primary objective of this process is to focus on laboratory performance, it will also highlight other common problems in the industry such as product adulteration by distributors and poor storge practices. Data from P-BAT should be publicly available so consumers can make informed decisions about their purchases based on the quality data derived from P-BAT. Doing so would further incentivize laboratories to serve and be accountable to the end consumer instead of cultivators and distributors.

Indexed as

CannabisLaboratory fraudQuality assuranceTransparentTrustless

Identifiers

PMID39833888
PMCPMC11748918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.